21. Mitochondrial disease Clinical trials / Disease details
Clinical trials : 33 / Drugs : 42 - (DrugBank : 32) / Drug target genes : 47 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03388528 (ClinicalTrials.gov) | September 8, 2017 | 27/10/2017 | Low Residue Diet Study in Mitochondrial Disease | Phase II Feasibility Study of the Efficacy and Acceptability of a Low Residue Diet in Adult Patients With Mitochondrial Disease | Mitochondrial Diseases | Dietary Supplement: Low Residue Diet Intervention | Newcastle University | Newcastle-upon-Tyne Hospitals NHS Trust | Completed | 18 Years | N/A | All | 36 | Phase 2 | United Kingdom |